Biotech FDA Granted Orphan Drug Designation of LBL-024, An Anti-PD-L1/4-1BB Bispecific Antibody Developed by Leads Biolabs, for Treatment of Neuroendocrine Cancer November 22, 2024
Biotech InxMed FAK Inhibitor Ifebemtinib Received Breakthrough Therapy Designation by China National Medical Products Administration for First-Line Non-Small Cell Lung Cancer (NSCLC) with KRAS G12C Mutation November 21, 2024
Biotech 111, Inc. to Participate in Fireside Chat with Water Tower Research on December 6, 2024 November 21, 2024
Biotech Thryv Therapeutics Announces the Appointment of Esteemed Executive Leader Amy Sehnert, MD, as Chief Medical Officer November 20, 2024
Biotech BIOVAXYS PARTNER SPAYVAC FOR WILDLIFE, INC., SCALES-UP VACCINE PRODUCTION CAPACITY November 20, 2024
Biotech Women’s Health Company Freya Biosciences Announces Key $10.4 Million Strategic Investment November 19, 2024
Biotech Monument Therapeutics Announces Appointment of Dr Stephen Brannan, Dr Jeff Baker and Dr Mark Treherne to its Advisory Board to Guide Schizophrenia Program November 19, 2024
Biotech Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE November 18, 2024
Biotech Bexion Pharmaceuticals, Inc. Announces Completion of Enrollment in Open Label Portion of Phase 1b/2 ASIST Study in mCRC November 18, 2024
Search
Biotech
November 22, 2024
November 21, 2024
November 21, 2024
November 21, 2024
November 20, 2024
November 20, 2024
November 19, 2024
November 19, 2024
November 18, 2024
November 18, 2024
